Bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activity
US12338255B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 17, 2023 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Jun 17, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application relates to novel bicyclic substituted sulfonylurea compounds and analogues, their manufacture, pharmaceutical compositions comprising them, and their use as medicaments for treating a disease associated with modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3, or inhibition of the activation of NLRP3 or related components of the inflammatory process.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.